Search

everythinglearnresearchcommunity

for

Search:↓

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A mother's iron levels early in pregnancy can influence the DNA makeup of her child, potentially affecting the child's health.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Genetic variations affecting skin structure play a key role in severe acne.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

PRP is an effective and safe treatment for female hair loss.

Women with irregular periods have a higher risk of heart disease.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Toxoplasma gondii infection may increase testosterone levels in males.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Lower SHBG levels may increase the risk of PCOS.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Platelet-rich plasma combined with other treatments improves acne scars better than those treatments alone.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

No genetic link between prostaglandins and hair loss found.